Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Sales | 12 | 0 | 0 | 0 | 0 |
| Gross Profit | 10 | 0 | 0 | 0 | 0 |
| Operating Expenses | 14,470 | 12,920 | 12,320 | 16,670 | 11,540 |
| Operating Income | -14,458 | -12,920 | -12,320 | -16,670 | -11,540 |
| Other Income | 218 | 20 | 110 | 250 | 280 |
| Pre-tax Income | -14,240 | -12,900 | -12,210 | -16,420 | -11,260 |
| Net Income Continuous | -14,247 | -12,875 | -12,220 | -16,429 | -11,267 |
| Net Income | $-14,247 | $-12,875 | $-12,220 | $-16,429 | $-11,267 |
| EPS Basic Total Ops | -13.21 | -13.82 | -13.21 | -17.68 | -12.20 |
| EPS Basic Continuous Ops | -13.21 | -13.88 | -13.19 | -17.74 | -12.18 |
| EPS Diluted Total Ops | -13.21 | -13.82 | -13.21 | -17.68 | -12.20 |
| EPS Diluted Continuous Ops | -13.21 | -13.88 | -13.19 | -17.74 | -12.18 |
| EBITDA(a) | $-14,128 | $-12,380 | $-12,040 | $-16,400 | $-11,290 |